Piper Sandler Downgrades Tandem Diabetes Care (TNDM) to Neutral
Piper Sandler analyst Matt O\'Brien downgraded Tandem Diabetes Care (NASDAQ: TNDM) from Overweight to Neutral with a price target of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
